Pluri Inc. Grants Receivable
Pluri Inc. (PLUR) had Grants Receivable of $293.00 thousand as of 2022-06-30, per its 10-K filed 2022-09-21.
Discontinued › Notes › Nontrade Receivables › Nontrade Receivables, Unclassified
us-gaap:GrantsReceivable · last filed 2022-09-21
- 2022-06-30: Grants Receivable $293.00K.
- 2021-06-30: Grants Receivable $566.00K.
- 2020-06-30: Grants Receivable $1.23M.
- 2013-12-31: Grants Receivable $13.89M.
| Period end | Grants Receivable |
|---|---|
| 2022-06-30 | $293.00K 10-K · filed 2022-09-21 |
| 2021-06-30 | $566.00K 10-K · filed 2022-09-21 |
| 2020-06-30 | $1.23M 10-K · filed 2021-09-13 |
| 2013-12-31 | $13.89M 10-Q · filed 2014-02-05 |
| 2013-06-30 | $10.88M 10-K · filed 2013-09-11 |
| 2012-06-30 | $9.41M 10-K · filed 2013-09-11 |
| 2011-06-30 | $6.26M 10-K · filed 2012-09-10 |
| 2011-02-28 | $244.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |